Randomized Trial: β Blockers to Prevent Decompensation of Cirrhosis in Patients with Portal Hypertension
26 Apr, 2019 | 02:07h | UTCβ blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial – The Lancet (link to abstract – $ for full-text)
Commentary: Beta-blockers linked to better outcomes in some patients with cirrhosis – ACP Gastroenterology (free)